SEATTLE — Rejuvenation MD is celebrating its 12th year in business with the opening of a brand‑new practice in Puyallup—its ...

Agios Pharmaceuticals (NASDAQ:AGIO) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline its ...

Geron (GERN) expects 2026 net product revenue in the range of $220M to $240M from its telomerase inhibitor RYTELO (imetelstat ...

Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS exposures in the projected therapeutic range, and target engagement with ...

Please provide your email address to receive an email when new articles are posted on . A 5-day azacitidine course had the most consistent survival benefit for low-risk MDS vs. other shorter ...

In an era when AI systems seem to be sparking concerns that computer science degrees may hold less value than in the past, Aaron Lauda said this new major will help students become “future-proof.” ...

In case you've faced some hurdles solving the clue, Org. for MDs, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...

KUALA LUMPUR, Sept 23 (Reuters) - The Malaysian Court of Appeal has overturned a High Court injunction that allowed Shell MDS (Malaysia) to halt its monthly gas payments to national energy firm ...

Malaysian state energy firm Petronas said on Wednesday that it remains committed to meeting its contractual obligations and maintaining reliable gas supply for buyers following a Court of Appeal ...

Geron Corporation (NASDAQ:GERN) is one of the best low priced pharma stocks to buy now. Earlier on May 28, Geron Corporation presented new data on RYTELO (imetelstat) at the 2025 American Society of ...

A new skilled nursing facility validation program could be the “tip of the iceberg” in verifying provider quality measurements and could lead to reduced incentives, reimbursement experts warned this ...